[1]
“OFF-LABEL USE OF PAMIDRONATE IN HYPER-CALCEMIC NEWBORN AFFECTED BY SUBCUTANEOUS FAT NECROSIS AFTER THERAPEUTIC HYPOTERMIA”, J Siena Acad Sci, vol. 3, no. 1, p. 84, Aug. 2012, doi: 10.4081/jsas.2011.583.